Tag: CBT > United Kingdom

Industry Headlines

UK’s Mamedica Announces £4.5M Funding Round Led by US-Based Casa Verde

The landmark investment will accelerate access to cannabis-based health care as the United Kingdom approaches a £1-billion valuation.

September 23, 2025

International

MediPharm Labs Expands Novel Cannabis Metered Dose Portfolio in EU, UK

The company began producing its first order for the international expansion under a sales and distribution agreement with Blackpoint.

May 27, 2025

Industry Headlines

Curaleaf Issues Report on Illicit Online Cannabis Sales, Urges UK Government Action

The international cannabis company’s report reveals serious health risks of mold, lead and synthetic cannabinoids in unregulated cannabis.

October 24, 2024

International

SOMAÍ Group, and Its Subsidiary, RPK Biopharma Expand Cookies Partnership to Include Europe and the UK

May 16, 2024

International

UK’S Medical Cannabis Boom: Patients, Demand and Consumption Surge to All-Time Highs - With a Record Number of Private Clinics

May 14, 2024

International

Curaleaf Acquires Northern Green Canada in Strategic International Expansion

The deal bolsters the company's advantage in several key emerging markets, including Australia, New Zealand, Germany, Poland and the United Kingdom.

April 22, 2024

International

Highest-THC Cannabis Doesn’t Mean Highest Price in Foreign Countries

In Australia, Germany, Israel and the United Kingdom, low-THC, mid-low-THC or mid-THC medical oil products command higher prices than high-THC products. Plus, how do U.S. flower product prices compare to those overseas?

February 7, 2024